{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:36:05Z","timestamp":1781217365142,"version":"3.54.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>to assess incidence, prognosis and obstetric outcome of patients treated for gestational trophoblastic disease GTD in a twenty-year period. Incidence, prognosis and obstetric outcome of gestational throphoblastic disease<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>retrospective study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-four cases of GTD: 46 (85.18%) cases of Hydatidiform mole (HM); 8 cases of Persistent Gestational Trophoblastic Neoplasia (GTN) (14.81%): 6\/8 cases (75%) GTN not metastatic; 2\/8 cases (25%) GTN metastatic. In both cases, the metastases occurred in the lungs. In 3 out of 8 GTN cases (37.5%) a histological picture of choriocarcinoma emerged. The incidence of GTD cases treated from 2000 to 2020 was 1.8 cases per 1000 deliveries and 1.3 cases per 1000 pregnancies. Of the 54 patients, 30 (55.56%) presented showed normal serum hCG levels without the need for chemotherapy. On the other hand, 24 patients (44.44%) developed a persistent trophoblastic disease and underwent adjuvant therapy. The negative prognostic factors that affected the risk of persistence of GTD were: serum hCG levels at diagnosis &amp;gt; 100,000 mUI\/ml; characteristic \u201c<jats:italic>snow storm<\/jats:italic>\u201d finding at the ultrasound diagnosis; a slow regression of serum hCG levels during follow-up; the persistence of high serum hCG levels (especially if &amp;gt; 1000 mUI\/ml one month after suction curettage) that was the main risk factor for resistance to first-line chemotherapy. There were 10 pregnancies in total following treatment. Patients\u2019 survival in our study was 100%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Although GTD is a rare disease, its incidence was 1.3 cases per 1,000 pregnancies in Sardinia, Italy, higher if compared with mean national and worldwide incidence.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.684700","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T14:17:53Z","timestamp":1620224273000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Giampiero","family":"Capobianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Tinacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dessole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Madonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Olivari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Adriano","family":"Santeufemia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Dessole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Cherchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational Trophoblastic Disease I: Epidemiology, Pathology, Clinical Presentation and Diagnosis of Gestational Trophoblastic Disease, and Management of Hydatidiform Mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.08.330","article-title":"15years of Progress in Gestational Trophoblastic Disease: Scoring, Standardization, and Salvage","volume":"144","author":"Brown","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B3","article-title":"Twenty-Five Years\u2019 Clinical Experience With Placental Site Trophoblastic Tumors","volume":"47","author":"Papadopoulos","year":"2002","journal-title":"J Reprod Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(09)60618-8","article-title":"Prognostic Markers and Long-Term Outcome of Placental-Site Trophoblastic Tumours: A Retrospective Observational Study","volume":"374","author":"Schmid","year":"2009","journal-title":"Lancet"},{"key":"B5","article-title":"Epidemiological Report on the Treatment of Patients With Gestational Trophoblastic Disease in 10 Brazilian Referral Centers: Results After 12 Years Since International Figo 2000 Consensus","volume":"59","author":"Braga","year":"2014","journal-title":"J Reprod Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1987.tb02311.x","article-title":"Incidence and Aetiology of Hydatidiform Mole: An Epidemiological Review","volume":"94","author":"Bracken","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational Trophoblastic Disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(84)90370-3","article-title":"Epidemiology of Gestational Trophoblastic Disease","volume":"150","author":"Grimes","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"B9","volume-title":"Gestational Trophoblastic Disease","author":"Handcock","year":"2009"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.09.005","article-title":"Current Management of Gestational Trophoblastic Diseases","volume":"112","author":"Berkowitz","year":"2009","journal-title":"Gynecol Oncol"},{"key":"B11","article-title":"Advances in the Epidemiology of Gestational Trophoblastic Disease","volume":"39","author":"Palmer","year":"1994","journal-title":"J Reprod Med"},{"key":"B12","article-title":"Trophoblastic Disease in the District of Sassari. Epidemiological Profile During Ten-Years Period 1974-83","author":"Cherchi","year":"1985","journal-title":"Proc Int Meet Gyn Oncol"},{"key":"B13","article-title":"Gestational Trophoblastic Disease in the Gynaecologic and Obstetric Institute of Sassari in the Period 1976-89","volume":"17","author":"Cherchi","year":"1990","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.072","article-title":"Gestational Trophoblastic Disease II: Classification and Management of Gestational Trophoblastic Neoplasia","volume":"204","author":"Lurain","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"B15","article-title":"Subsequent Pregnancy Outcomes After Complete and Partial Molar Pregnancy, Recurrent Molar Pregnancy, and Gestational Trophoblastic Neoplasia: An Update From the New England Trophoblastic Disease Center","volume":"59","author":"Vargas","year":"2014","journal-title":"J Reprod Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0002-9378(85)80115-0","article-title":"Risk Factors for Gestational Trophoblastic Neoplasia","volume":"153","author":"Messerli","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1986.tb07957.x","article-title":"Parental Age and Risk of Complete and Partial Hydatidiform Mole","volume":"93","author":"Parazzini","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1471-0528.2002.t01-1-01037.x","article-title":"Risk of Partial and Complete Hydatidiform Molar Pregnancy in Relation to Maternal Age","volume":"109","author":"Sebire","year":"2002","journal-title":"BJOG"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00268-V","article-title":"The Changing Clinical Presentation of Complete Molar Pregnancy","volume":"86","author":"Soto-Wright","year":"1995","journal-title":"Obstet Gynecol"},{"key":"B20","article-title":"Valutazione Statistica Di Alcuni Dati Epidemiologici Concernenti La Mola Idatidea [Statistical Evaluation of Some Epidemiological Data Concerning Hydatidiform Mole]","volume":"57","author":"Di Fabio","year":"1976","journal-title":"Riv Ital Ginecol."},{"key":"B21","article-title":"The Incidence of Gestational Trophoblastic Disease in Italy: A Multicenter Survey","volume":"57","author":"Salerno","year":"2012","journal-title":"J Reprod Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/j.1879-3479.1977.tb00717.x","article-title":"High Frequency of Hydatidiform Mole in Native Alaskans","volume":"15","author":"Martin","year":"1978","journal-title":"Int J Gynaecol Obstet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.064196","article-title":"Identification of 13 Novel Nlrp7 Mutations in 20 Families With Recurrent Hydatidiform Mole; Missense Mutations Cluster in the Leucine-Rich Region","volume":"46","author":"Wang","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114337","article-title":"Choriocarcinoma Incidence in the United States","volume":"123","author":"Brinton","year":"1986","journal-title":"Am J Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200311000-00017","article-title":"Trends in Gestational Choriocarcinoma: A 27-Year Perspective","volume":"102","author":"Smith","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.02388.x","article-title":"Risk of Recurrent Hydatidiform Mole and Subsequent Pregnancy Outcome Following Complete or Partial Hydatidiform Molar Pregnancy","volume":"110","author":"Sebire","year":"2003","journal-title":"BJOG"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.bjc.6600041","article-title":"The Effect of Early Pregnancy Following Chemotherapy on Disease Relapse and Foetal Outcome in Women Treated for Gestational Trophoblastic Tumours","volume":"86","author":"Blagden","year":"2002","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.10.035","article-title":"Prediction of Persistent Gestational Trophobalstic Neoplasia: The Role of Hcg Level and Ratio in 2 Weeks After Evacuation of Complete Mole","volume":"124","author":"Kang","year":"2012","journal-title":"Gynecol Oncol"},{"key":"B29","article-title":"Gestational Trophoblastic Neoplasia: Where We Came From, Where We Stand Today, Where We are Heading. Keynote Address","volume":"55","author":"Goldstein","year":"2010","journal-title":"J Reprod Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200304000-00020","article-title":"Human Chorionic Gonadotropin Follow-Up in Patients With Molar Pregnancy: A Time for Reevaluation","volume":"101","author":"Feltmate","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31829703ea","article-title":"Linear Regression of Postevacuation Serum Human Chorionic Gonadotropin Concentrations Predicts Postmolar Gestational Trophoblastic Neoplasia","volume":"23","author":"Lybol","year":"2013","journal-title":"Int J Gynecol Cancer."},{"key":"B32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejogrb.2021.01.051","article-title":"Obstetrics Outcomes After Complete and Partial Molar Pregnancy: Review of the Literature and Meta-Analysis","volume":"259","author":"Capozzi","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.684700\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T13:07:01Z","timestamp":1620306421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.684700\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":32,"alternative-id":["10.3389\/fonc.2021.684700"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.684700","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"article-number":"684700"}}